These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 20501525)

  • 1. Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice.
    Wang S; Yang N; Zhang L; Huang B; Tan H; Liang Y; Li Y; Yu X
    Lupus; 2010 Sep; 19(10):1171-80. PubMed ID: 20501525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Jak/STAT signaling ameliorates mice experimental nephrotic syndrome.
    Li R; Yang N; Zhang L; Huang Y; Zhang R; Wang F; Luo M; Liang Y; Yu X
    Am J Nephrol; 2007; 27(6):580-9. PubMed ID: 17823504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockage of JAK/STAT signalling attenuates renal ischaemia-reperfusion injury in rat.
    Yang N; Luo M; Li R; Huang Y; Zhang R; Wu Q; Wang F; Li Y; Yu X
    Nephrol Dial Transplant; 2008 Jan; 23(1):91-100. PubMed ID: 17670769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
    Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
    Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L; Chen HP; Ma Q
    Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antagonist of the JAK-1/STAT-1 signaling pathway improves the severity of cerulein-stimulated pancreatic injury via inhibition of NF-κB activity.
    Chen P; Huang L; Zhang Y; Qiao M; Yao W; Yuan Y
    Int J Mol Med; 2011 May; 27(5):731-8. PubMed ID: 21369693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Muraoka M; Hasegawa H; Kohno M; Inoue A; Miyazaki T; Terada M; Nose M; Yasukawa M
    Arthritis Rheum; 2006 Nov; 54(11):3591-600. PubMed ID: 17075801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
    Lu LD; Stump KL; Wallace NH; Dobrzanski P; Serdikoff C; Gingrich DE; Dugan BJ; Angeles TS; Albom MS; Mason JL; Ator MA; Dorsey BD; Ruggeri BA; Seavey MM
    J Immunol; 2011 Oct; 187(7):3840-53. PubMed ID: 21880982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK/STAT signaling controls the fate of CD8
    Zhou M; Guo C; Li X; Huang Y; Li M; Zhang T; Zhao S; Wang S; Zhang H; Yang N
    J Autoimmun; 2020 May; 109():102424. PubMed ID: 32085893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the STAT1 signalling pathway in lupus nephritis in MRL/lpr mice.
    Dong J; Wang QX; Zhou CY; Ma XF; Zhang YC
    Lupus; 2007; 16(2):101-9. PubMed ID: 17402366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of JAK/STAT signaling pathway prevents high-glucose-induced increase in endothelin-1 synthesis in human endothelial cells.
    Manea SA; Manea A; Heltianu C
    Cell Tissue Res; 2010 Apr; 340(1):71-9. PubMed ID: 20217138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ac-SDKP ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Tan H; Zhao J; Wang S; Zhang L; Wang H; Huang B; Liang Y; Yu X; Yang N
    Int Immunopharmacol; 2012 Dec; 14(4):401-9. PubMed ID: 22922317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion.
    Freitas MC; Uchida Y; Zhao D; Ke B; Busuttil RW; Kupiec-Weglinski JW
    Liver Transpl; 2010 May; 16(5):600-10. PubMed ID: 20440769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAK3-STAT pathway blocking benefits in experimental lupus nephritis.
    Ripoll È; de Ramon L; Draibe Bordignon J; Merino A; Bolaños N; Goma M; Cruzado JM; Grinyó JM; Torras J
    Arthritis Res Ther; 2016 Jun; 18(1):134. PubMed ID: 27278657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reno-Protective Effect of Realgar Nanoparticles on Lupus Nephritis of MRL/Lpr Mice through STAT1.
    Xu W; Chen Z; Shen X; Pi C
    Iran J Immunol; 2019 Jun; 16(2):170-181. PubMed ID: 31182691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A; Nakashima H; Masutani K; Miyake K; Shimizu S; Igawa T; Sugiyama N; Niiro H; Hirakata H; Harada M
    Arthritis Rheum; 2005 Dec; 52(12):3987-96. PubMed ID: 16320345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
    Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M
    Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AG490, a Jak2 inhibitor, suppressed the progression of murine ovarian cancer.
    Kobayashi A; Tanizaki Y; Kimura A; Ishida Y; Nosaka M; Toujima S; Kuninaka Y; Minami S; Ino K; Kondo T
    Eur J Pharmacol; 2015 Nov; 766():63-75. PubMed ID: 26410360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice.
    Shimizu S; Nakashima H; Masutani K; Inoue Y; Miyake K; Akahoshi M; Tanaka Y; Egashira K; Hirakata H; Otsuka T; Harada M
    Rheumatology (Oxford); 2004 Sep; 43(9):1121-8. PubMed ID: 15213333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.